JOHN E. BENNETT, M.D.; JACK S. REMINGTON, M.D.
This content is PDF only. Please click on the PDF icon to access.
An article in a recent issue of this journal reported the use of intravenous miconazole in cryptococcosis (1). Use of this new antifungal drug in the treatment of systemic candidiasis as well as cryptococcosis appears to be increasing. Whereas relatively few infectious disease specialists use intravenous miconazole for these indications, we believe that this drug is used much more frequently by physicians working outside the subspecialty of infectious disease. If our impression is correct, then these groups differ in the interpretation of the meager data on the efficacy of miconazole in treating these diseases. Alternatively, some physicians may be relying
BENNETT JE, REMINGTON JS. Miconazole in Cryptococcosis and Systemic Candidiasis: A Word of Caution. Ann Intern Med. 1981;94:708–709. doi: 10.7326/0003-4819-94-5-708
Download citation file:
Published: Ann Intern Med. 1981;94(5):708-709.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use